Sponsor study identifier
observational
720
1 country
1
Study Start
January 26, 2023
Actual (reported)Primary Completion
July 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The aim of the study is to investigate the confounding factors of chronic endometritis and therapeutic benefits of antibodies targeting plasma cells in women with reproductive failure.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 3, 2022
Actual (reported)November 14, 2022
Actual (reported)January 26, 2023
Actual (reported)July 31, 2027
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
January 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Live birth rate
compare the brith rate between the group and cohort
31 December 2027
Compare the pregnancy rate between groups
31 March 2028
Compare the miscarriage rate between groups
31 March 2028
Compare the implantation rate between groups
31 March 2028
Patients have 2 or more miscarriage or repeated implantation failure (RIF), or infertile women would be invited to do endometrial sampling (ES) procedure. The ES will be conducted randomly or when women undergo hysteroscopy or obtained precisely 7 days after LH surge. It will be obtained using a Pipelle sampler as an outpatient procedure.
Subjects will be identified and recruited from the IVF and miscarriage clinic by clinicians and research nurse.
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Patient will be invited to do endometrial sampling
Jacqueline Pui Wah Chung, MBBS
Chinese University of Hong Kong
First Submitted
November 3, 2022
First Posted
November 14, 2022
Study Start
January 26, 2023
Actual (reported)Primary Completion
July 31, 2027
EstimatedEffect of Reducing the Oxygen Concentration From 5% to 2% on ICSI Outcome
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
January 31, 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
March 27, 2025
Record last verified: 2025-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: